Cerecor Inc (CERC) Director Acquires $21,840.00 in Stock

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc acquired 4,000 shares of Cerecor stock in a transaction on Friday, March 8th. The shares were bought at an average price of $5.46 per share, with a total value of $21,840.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Armistice Capital, Llc also recently made the following trade(s):

Get Cerecor alerts: On Wednesday, March 6th, Armistice Capital, Llc acquired 125,486 shares of Cerecor stock. The shares were bought at an average price of $5.50 per share, with a total value of $690,173.00. On Friday, January 11th, Armistice Capital, Llc acquired 12,651 shares of Cerecor stock. The shares were bought at an average price of $3.90 per share, with a total value of $49,338.90. On Wednesday, January 9th, Armistice Capital, Llc acquired 545 shares of Cerecor stock. The shares were bought at an average price of $3.79 per share, with a total value of $2,065.55. On Monday, January 7th, Armistice Capital, Llc acquired 6,504 shares of Cerecor stock. The shares were bought at an average price of $3.65 per share, with a total value of $23,739.60. On Friday, January 4th, Armistice Capital, Llc acquired 20,000 shares of Cerecor stock. The shares were bought at an average price of $3.42 per share, with a total value of $68,400.00. On Monday, December 31st, Armistice Capital, Llc acquired 12,300 shares of Cerecor stock. The shares were bought at an average price of $3.18 per share, with a total value of $39,114.00. On Friday, December 28th, Armistice Capital, Llc acquired 26,499 shares of Cerecor stock. The shares were bought at an average price of $3.12 per share, with a total value of $82,676.88. On Monday, December 31st, Armistice Capital, Llc acquired 12,300 shares of Cerecor stock. The shares were bought at an average price of $3.18 per share, with a total value of $39,114.00. On Friday, December 28th, Armistice Capital, Llc acquired 26,499 shares of Cerecor stock. The shares were bought at an average price of $3.12 per share, with a total value of $82,676.88. On Monday, December 17th, Armistice Capital, Llc acquired 14,938 shares of Cerecor stock. The shares were bought at an average price of $3.26 per share, with a total value of $48,697.88.

Shares of Cerecor stock traded down $0.01 during trading hours on Friday, reaching $5.51. 122,200 shares of the company’s stock were exchanged, compared to its average volume of 123,476. Cerecor Inc has a 1 year low of $2.71 and a 1 year high of $7.65. The firm has a market capitalization of $216.67 million, a price-to-earnings ratio of 13.12 and a beta of 2.16. The company has a quick ratio of 0.70, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Several institutional investors have recently added to or reduced their stakes in CERC. Northern Trust Corp grew its holdings in shares of Cerecor by 47.9% during the fourth quarter. Northern Trust Corp now owns 20,079 shares of the company’s stock worth $65,000 after buying an additional 6,500 shares in the last quarter. BlackRock Inc. grew its holdings in shares of Cerecor by 18.5% during the fourth quarter. BlackRock Inc. now owns 33,960 shares of the company’s stock worth $109,000 after buying an additional 5,293 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Cerecor during the third quarter worth $169,000. Geode Capital Management LLC grew its holdings in shares of Cerecor by 50.7% during the fourth quarter. Geode Capital Management LLC now owns 94,990 shares of the company’s stock worth $306,000 after buying an additional 31,951 shares in the last quarter. Finally, Vanguard Group Inc grew its holdings in shares of Cerecor by 10.1% during the third quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock worth $411,000 after buying an additional 8,094 shares in the last quarter. 44.33% of the stock is owned by institutional investors and hedge funds.

A number of research firms have recently issued reports on CERC. LADENBURG THALM/SH SH reaffirmed a “buy” rating and set a $9.00 target price on shares of Cerecor in a report on Thursday, January 17th. ValuEngine lowered shares of Cerecor from a “strong-buy” rating to a “buy” rating in a report on Thursday. TheStreet raised shares of Cerecor from a “d” rating to a “c” rating in a report on Monday, November 12th. Finally, BidaskClub raised shares of Cerecor from a “buy” rating to a “strong-buy” rating in a report on Friday, March 1st.

COPYRIGHT VIOLATION NOTICE: “Cerecor Inc (CERC) Director Acquires $21,840.00 in Stock” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4207588/cerecor-inc-cerc-director-acquires-21840-00-in-stock.html.

Cerecor Company Profile

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Further Reading: How to track put option volume